Aytu Biopharma Inc Share Price

NASDAQ: AYTU

Small Cap

$2.37

+0.05

(+2.20%)

Live

as on September 18, 2025 at 8:29 pm IST

$₹

Aytu Biopharma Inc Stock Performance

as on September 18, 2025 at 8:29 pm IST

Day's Low
$2.32
Day's Price Range
$2.37
$2.37
2.11%
Downside
52 Week's Low
52 Week's High
$0.95
52-Week Price Range
$2.85
$2.37
59.92%
Downside
20.25%
Upside

Aytu Biopharma Inc share price movements today

Previous Close: $2.32
Open: $2.37
Volume: 46.1K
Day's Low - High: $2.32 - $2.37
52 Week Low - High: $0.95 - $2.85

Aytu Biopharma Inc Historical Returns

1 Month Return: + 5.45 %
3 Month Return: + 17.77 %
1 Year Return: -6.07 %
3 Year Return: -44.5 %
5 Year Return: -99.16 %

Aytu Biopharma Inc Stock Fundamentals & Key Indicators

Check Aytu Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$21.0M

EPS (TTM)

0.15

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

6.0M

Revenue (TTM)

81.7M

Profit Margin

2.01%

Return On Equity TTM

160600.00%

Aytu Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aytu Biopharma Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Aytu Biopharma Inc	BUY	$21.0M	-99.16%	NA	2.01%
United Therapeutics Corporation	BUY	$18.3B	NA	15.75	40.36%
Haleon Plc Spon Ads	BUY	$42.0B	NA	20.89	13.81%
Neurocrine Biosciences Inc.	BUY	$14.2B	40.41%	42.23	13.88%
Zoetis Inc.	BUY	$65.1B	-8.67%	25.29	27.83%

Stock Returns calculator for Aytu Biopharma Inc Stock including INR - Dollar returns

The Aytu Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y
3Y
5Y
7Y

Aytu Biopharma Inc investment value today

Current value as on today

₹1,00,905

Returns

₹905

(+0.90%)

Returns from Aytu Biopharma Inc Stock

₹4,049 (-4.05%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Aytu Biopharma Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Aytu Biopharma Inc. Average target price of $9.67

Aytu Biopharma Inc Share Price Target

Get share price movements and forecasts by analysts on Aytu Biopharma Inc.

What analysts predicted

75.49%UPSIDE

Target Price

$9.67

Current Price

$2.37

Analyzed by

7 Analysts

Target

$9.67

Aytu Biopharma Inc target price $9.67, a slight upside of 75.49% compared to current price of $2.37. According to 7 analysts rating.

Aytu Biopharma Inc Stock's Interest Amongst Investors

Search interest for Aytu Biopharma Inc Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-9% versus previous 30 day period

Aytu Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	26	22	30	17	22	14	17	16	16	18
Gross Profit	17	12	18	13	14	11	11	11	10	12
Operating Income	-4	-9	2	-1	3	-2	-3	0	-1	2
EBITDA	-1	-7	-	0	4	1	-5	3	2	6
Interest Expense	2	1	-	1	1	1	4	0	1	0
Depreciation	2	2	1	2	2	1	1	1	1	1
Income Before Tax	-6	-7	-2	-8	0	-2	-3	1	0	3
Income Tax Expense	1	-1	-	-2	0	0	0	0	0	0
Net Income	-6	-7	-2	-8	0	-2	-4	1	0	3
Net Profit Margin	-25.46%	-31.67%	-7.99%	-45.57%	-0.96%	-20.61%	-25.68%	8.89%	4.86%	21.65%

Aytu Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024
Total Revenue	0	2	3	3	7	27	65	96	107	81
Gross Profit	0	1	1	1	5	20	29	46	66	49
Operating Income	-7	-21	-20	-19	-16	-20	-58	-109	-17	-5
EBITDA	-7	-21	-18	-15	-14	-12	-29	-98	-3	-1
Interest Expense	0	5	2	0	-	-	37	147	4	4
Depreciation	-	-	4	2	2	6	9	10	4	8
Income Before Tax	-7	-28	-22	-10	-27	-13	-58	-108	-17	-14
Income Tax Expense	0	8	1	-2	20	-9	0	0	0	1
Net Income	-7	-28	-22	-10	-47	-13	-58	-108	-17	-15
Net Profit Margin	-2950.32%	-1099.73%	-698.67%	-278.36%	-644.33%	-49.29%	-88.81%	-112.53%	-15.88%	-19.56%

Aytu Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Net Income	-7	-2	-8	-2	-4	1	0	3
Operating Cash Flow	-2	9	0	0	0	-1	2	-6
Investing Cash Flow	0	0	0	0	0	0	0	0
Financing Cash Flow	2	-5	-2	0	1	0	-2	4
Change in Cash	0	3	-3	0	0	0	0	-2

Aytu Biopharma Inc Annual Cash Flow

All numbers in Millions USD

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024
Net Income	-28	-22	-10	-27	-13	-58	-110	-17	-15
Operating Cash Flow	-10	-13	-15	-13	-28	-25	-28	-5	-1
Investing Cash Flow	-5	-3	0	-1	-5	-2	-3	0	0
Financing Cash Flow	16	10	22	19	71	30	1	8	-1
Change in Cash	0	-7	6	4	37	1	-30	3	-2

Global Institutional Holdings in Aytu Biopharma Inc

Funds	Holdings
Nantahala Capital Management, LLC	12.11%
Kanen Wealth Management LLC	6.39%
Stonepine Capital Management Llc	5.17%
Renaissance Technologies Corp	0.86%
Armistice Capital, LLC	0.64%

See all

Insights on Aytu Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 788.0K → 3.99M (in $), with an average increase of 80.3% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 16.22M → 18.45M (in $), with an average increase of 12.1% per quarter
POSITIVE IMPACT
Price Rise
In the last 6 months, AYTU stock has moved up by 96.6%
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation has given 34.5% return, outperforming this stock by 79.0%
NO EFFECT
Against Peers
In the last 1 year, Neurocrine Biosciences Inc. has given 19.1% return, outperforming this stock by 25.2%

About Aytu Biopharma Inc

aytu bioscience is a specialty healthcare company focused on developing and commercializing novel products in the field of urology. aytu is initially concentrating on prostate cancer, male premature ejaculation and male infertility and plans to expand into other urological indications for which there are significant medical needs. the company currently markets prostascint®, an fda-approved radioimaging agent indicated to detect prostate specific membrane antigen (psma) in the assessment and staging of prostate cancer. the company’s most advanced therapeutic is zertane™, an oral therapeutic entering phase 3 clinical studies in the united states as an as needed treatment for premature ejaculation (pe). aytu is also conducting clinical trials with the company’s mioxsys™ system as a novel, point-of-care diagnostic system with the potential to become a standard of care in the diagnosis and management of male infertility.

Organisation	Aytu Biopharma Inc
Headquarters	Denver Corporate Center III, Denver, CO, United States, 80237
Industry	Consumer Services
CEO	Mr. Joshua R. Disbrow
E-voting on shares	Click here to vote

Key Management of Aytu Biopharma Inc

Name	Title
Mr. Joshua R. Disbrow	CEO & Director
Mr. Jarrett T. Disbrow Ph.D.	Chief Business Officer
Mr. Greg Pyszczymuka	Chief Commercial Officer
Mr. Ryan J. Selhorn CPA	CFO, Corporate Secretary & Treasurer
Ms. Margaret Cabano	Vice President of Operations

FAQs

What is Aytu Biopharma Inc share price today?

Aytu Biopharma Inc share price today is $2.37 as on September 18, 2025 at 8:29 pm IST. Aytu Biopharma Inc share today touched a day high of $2.37 and a low of $2.32.

What is the 52 week high and 52 week low for Aytu Biopharma Inc share?

Aytu Biopharma Inc share touched a 52 week high of $2.85 on September 26, 2024 and a 52 week low of $0.95 on April 7, 2025. Aytu Biopharma Inc stock price today i.e. September 18, 2025 at 8:29 pm IST is trending at $2.37,which is 16.84% down from its 52 week high and 149.47% up from its 52 week low.

What is Aytu Biopharma Inc's market capitalisation today?

Aytu Biopharma Inc market capitalisation is $0.00T as on September 18, 2025 at 8:29 pm IST.

How to invest in Aytu Biopharma Inc Stock (AYTU) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Aytu Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aytu Biopharma Inc Shares that will get you 0.6329 shares as per Aytu Biopharma Inc share price of $2.37 per share as on September 18, 2025 at 8:29 pm IST.

What is the minimum amount required to buy Aytu Biopharma Inc Stock (AYTU) from India?

Indian investors can start investing in Aytu Biopharma Inc (AYTU) shares with as little as ₹88.114 or $1 (as of September 18, 2025 at 8:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Aytu Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 8:43 pm IST). Based on Aytu Biopharma Inc share’s latest price of $2.37 as on September 18, 2025 at 8:29 pm IST, you will get 4.2194 shares of Aytu Biopharma Inc. Learn more about fractional shares .

What are the returns that Aytu Biopharma Inc has given to Indian investors in the last 5 years?

Aytu Biopharma Inc stock has given -99.16% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?